pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Sionna Therapeutics, Inc. ($SION) · news · pharmadog
← back to Sionna Therapeutics, Inc.
News mentioning $SION
81
stories
Jul 8, 26
Sanofi offers to end disparaging claims against CSL flu shot in Europe
endpoints
Jul 7, 26
Vera's IgAN approval kicks off competition with Otsuka
endpoints
Jul 7, 26
Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filing
endpoints
Jun 30, 26
AbbVie and Genmab's latest win brings Epkinly closer to label expansion
endpoints
Jun 30, 26
Sarepta's FDA decision date; Flare gets Anna Protopapas as CEO
endpoints
Jun 30, 26
Nominations are open for the 2026 Endpoints 11 awards
endpoints
Jun 30, 26
Beeline adds $126M to Bain-backed immunology pipeline from Bristol Myers
endpoints
Jun 30, 26
BeOne’s Brukinsa succeeds in frontline mantle cell lymphoma study
endpoints
Jun 30, 26
House China panel probes Bristol Myers, Pfizer on use of trial sites
endpoints
Jun 29, 26
John Reed on J&J’s R&D model, oncology deals and pipeline expansion potential
endpoints
Jun 20, 26
Endpoints News History: 10 Years, Bootstrap to FT
endpoints
Jun 17, 26
FDA gives rejected drugs another chance in post-Makary era
endpoints
Jun 16, 26
Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill
endpoints
Jun 15, 26
FDA plans to keep Makary priorities on trials, China, deputy says
endpoints
Jun 15, 26
Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staff
endpoints
Jun 15, 26
Six leaders working on LGBTQ+ inclusion in biopharma
endpoints
Jun 15, 26
HMNC Brain Health raises $50M Series B to advance two depression drugs
endpoints
Jun 12, 26
WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list
endpoints
Jun 10, 26
Rare disease biotech Beren adds $300M from new financings
endpoints
Jun 8, 26
GSK inks multi-target pact with Engitix; Sangamo considers strategic options
endpoints
Jun 5, 26
Industry seeks more clarity on commissioner's voucher program
endpoints
Jun 4, 26
Acting FDA chief isn't interested in permanent role
endpoints
Jun 4, 26
Acting FDA commissioner pledges to prevent political interference in rare disease meeting
endpoints
Jun 4, 26
Dimension seeks up to $750M for third life sciences fund after string of success
endpoints
Jun 4, 26
Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug
endpoints
Jun 4, 26
Supreme Court sides with Hikma in 'skinny label' case
endpoints
Jun 3, 26
Mineralys makes money moves before looming hypertension approval
endpoints
Jun 2, 26
#ASCO26: Celcuity plans another FDA filing after positive breast cancer readout
endpoints
Jun 2, 26
Praxis sinks on late-stage study fail for seizure pill, halts second trial
endpoints
May 29, 26
#ASCO26: Bristol Myers details Phase 3 trial win for Pomalyst successor
endpoints
← prev
page 2 of 3
next →
